SCHEMBL393967

SCHEMBL393967

Cc1[nH]c(C=C2C(=O)Nc3cc(Oc4cccc(NC(=O)c5cccc(C(F)(F)F)c5)c4)ccc32)c(C)c1C(=O)NCCCN1CCCC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 5/20 0.59
PDGFRB P09619 4/20 0.59
FLT3 P36888 4/20 0.59
AURKB Q96GD4 4/20 0.59
MET P08581 1/20 0.59
NTRK2 Q16620 1/20 0.59
AURKA O14965 1/20 0.56
LCK P06239 1/20 0.56
KIT P10721 1/20 0.56
KCNH2 Q12809 1/20 0.56
FGFR1 P11362 2/20 0.54
TLK2 Q86UE8 1/20 0.54
NTRK1 P04629 2/20 0.53
PRKAA2 P54646 4/20 0.45
PRKAA1 Q13131 4/20 0.45
LRRK2 Q5S007 1/20 0.45
CSF1R P07333 2/20 0.45
NTRK3 Q16288 1/20 0.44
HDAC3 O15379 2/20 0.44
HDAC4 P56524 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10091926 1.00 KDR (0.59) KDRPDGFRBFLT3AURKBMET
SCHEMBL10091927 0.92 KDR (0.59) KDRPDGFRBFLT3AURKBMET
SCHEMBL396168 0.92 KDR (0.59) KDRPDGFRBFLT3AURKBMET
SCHEMBL396374 0.91 NTRK2 (0.70) KDRPDGFRBFLT3AURKBMET
SCHEMBL10091902 0.91 NTRK2 (0.70) KDRPDGFRBFLT3AURKBMET
SCHEMBL10091855 0.89 KDR (0.67) KDRPDGFRBFLT3AURKBMET
SCHEMBL399112 0.89 KDR (0.67) KDRPDGFRBFLT3AURKBMET
SCHEMBL395050 0.89 NTRK2 (0.66) KDRPDGFRBFLT3AURKBMET
SCHEMBL10091925 0.89 NTRK2 (0.66) KDRPDGFRBFLT3AURKBMET
SCHEMBL10091900 0.88 NTRK2 (0.69) KDRPDGFRBFLT3AURKBMET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8101608-B2 3-(4-Methyl-imidazol-1-yl)-N-{3-[2-oxo-3-(1H-pyrrol-2-ylmethylene)-2,3-dihydro-1H-indol-6-ylamino]-phenyl}-5-trifluoromethyl-benzamide; including benign and malignant proliferative disorders as well as diseases resulting from inappropriate activation of the immune and nervous systems IRM LLC, a Delware Limited Corporation (BM) 2012-01-24 US claimed
US-8101608-B2 3-(4-Methyl-imidazol-1-yl)-N-{3-[2-oxo-3-(1H-pyrrol-2-ylmethylene)-2,3-dihydro-1H-indol-6-ylamino]-phenyl}-5-trifluoromethyl-benzamide; including benign and malignant proliferative disorders as well as diseases resulting from inappropriate activation of the immune and nervous systems IRM LLC, a Delware Limited Corporation (BM) 2012-01-24 US disclosed